Search results
Results from the WOW.Com Content Network
CEO of Aerie Pharmaceuticals Inc (30-Year Financial, Insider Trades) Vicente Jr Anido (insider trades) bought 26,250 shares of AERI on 09/09/2019 at an average price of $19.01 a share. Continue ...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients with glaucoma or ocular hypertension. [1] [2] [3] In August 2022, Swiss eye-care firm Alcon agreed to buy Aerie Pharmaceuticals for US$770 million. [4] The acquisition completed in November 2022. [5]
The S&P 500 is a stock market index maintained by S&P Dow Jones Indices. It comprises 503 common stocks which are issued by 500 large-cap companies traded on the American stock exchanges (including the 30 companies that compose the Dow Jones Industrial Average). The index includes about 80 percent of the American market by capitalization.
In this article you are going to find out whether hedge funds think Aerie Pharmaceuticals Inc (NASDAQ:AERI) is a good investment right now. We like to check what the smart money thinks first ...
A corporation can adjust its stock price by a stock split, substituting a quantity of shares at one price for a different number of shares at an adjusted price where the value of shares x price remains equivalent. (For example, 500 shares at $32 may become 1000 shares at $16.) Many major firms like to keep their price in the $25 to $75 price range.
However, at the current price, it trades at only 26 times trailing-12-month earnings, a discount to the S&P 500 average. ... The Stock Advisor service has more than quadrupled the return of S&P ...